Latest / The BioHub - by Avetix
Episode 69 - Nolan Townsend - CEO of Lexeo Therapeutics
Welcome back to another episode of The BioHub, we were thrilled to welcome on Nolan Townsend, CEO of Lexeo Therapeutics.Nolan has been at the helm of Lexeo since January 2020, leading a clinical-stage genetic medicine company aiming to transform treatment for genetically-defined cardiovascular diseases and APOE4-associated Alzheimer’s disease.
Under his leadership, Lexeo has built a pipeline of therapies rooted in breakthrough science, partnered with prominent academic institutions like Weill Cornell Medicine, and raised significant capital to support its mission. Before Lexeo, Nolan spent…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.